MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds

case studies

Product utilization data analysis informs biotech growth strategy


Collecting and Leveraging Utilization Data to Drive Growth


Large US-based biotechnology company

Name of service provided

Market Access


A biotechnology company sought detailed product utilization data by indication and line of therapy, and commercialization strategy support to help identify opportunities to improve access to its product. They wanted to better understand product utilization trends based on indication, geography, and line of therapy, with a particular focus on the client’s key accounts.


First, we defined the patient population of interest based on diagnosis codes and product use during specific periods. Our clinical subject matter experts then worked iteratively with the client to define a “claims-based logic” that our analytics team used to classify patients of interest and identify the relevant cohort. Before beginning our analysis, we presented table shells and visualization designs to ensure the final deliverables would meet the client’s needs.

Our claims analysis—which leveraged our access to 100% fee-for-service claims data—contained several measures of utilization, including unique beneficiaries, unique claims, and product units. We stratified the results to provide targeted insights by indication, line of therapy, and account-level use. In addition, we aggregated our account-level analysis to the practice ownership level to compare utilization across accounts under the same parent organization. We then generated data visualizations to reveal patterns within and across accounts and to compare changes over time

Priority product and competitor market share, Medicare Part B claims, by quarter

Priority product and competitor market share, Medicare Part B claims, by quarter

Figure 1. Utilization Trends by Product

Line of therapy analysis, Medicare Part B claims, last 12 months

Line of therapy analysis, Medicare Part B claims, last 12 months

Figure 2. Utilization Trends by Line of Therapy


The client’s sales and marketing teams are using these data to distinguish market share across different sectors and grow their business strategically. The client’s market access analytics team, which sponsored this project, shares project insights with cross-functional teams across the organization to support the policy, market access strategy, sales, and commercial teams.

Manufacturers in the relevant therapeutic area face increased competition from new product approvals and the entry of biosimilars. We refresh the analytics quarterly to provide the client with robust, current results to help it drive its business strategy.

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement


Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.